Maximilian Hoffmann
Person

Affiliations

Institute of Pharmacology and Toxicology
- Academic Staff
- maximilian.hoffmann@tu-dresden.de
Institute of Clinical Pharmacology
- Academic Staff
- maximilian.hoffmann@tu-dresden.de

Identification Numbers

ORCID	0000-0003-3427-8409
Scopus author ID	57217009571

Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice

Künzel, S. R., Winter, L., Hoffmann, M., Kant, T. A., Thiel, J., Kronstein‐Wiedemann, R., Klapproth, E., & 3 othersLorenz, K., El‐Armouche, A. & Kämmerer, S., Sept 2023, In: Physiological reports. 11, 17, e15809.

Research output: Contribution to journal › Research article › Contributed › peer-review

Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation

Künzel, S. R., Hoffmann, M., Weber, S., Künzel, K., Kämmerer, S., Günscht, M., Klapproth, E., & 25 othersRausch, J. S. E., Sadek, M. S., Kolanowski, T., Meyer-Roxlau, S., Piorkowski, C., Tugtekin, S. M., Rose-John, S., Yin, X., Mayr, M., Kuhlmann, J. D., Wimberger, P., Grützmann, K., Herzog, N., Küpper, J-H., O’Reilly, M., Kabir, S. N., Sommerfeld, L. C., Guan, K., Wielockx, B., Fabritz, L., Nattel, S., Ravens, U., Dobrev, D., Wagner, M. & El-Armouche, A., Oct 2021, In: Circulation research.

Research output: Contribution to journal › Research article › Contributed › peer-review

Research Portal of the TU Dresden

Maximilian Hoffmann
Person

Affiliations

Identification Numbers

Related content

Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice

Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation

Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient mice

Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype

Repurposing mesalazine against cardiac fibrosis in vitro

Erich-Glowatzky-Preis